STAT+: Pharmalittle: We’re reading about the FDA listing Novo drugs as ‘available,’ pharma layoffs, and more
STAT
OCTOBER 31, 2024
Of course, this calls for a cup of stimulation, and we are opening a new package of pecan pie for the occasion. … All doses of Novo Nordisk’s blockbuster diabetes and obesity treatments are listed as available on the U.S. What is upon us right now, however, is our ever-growing to-do list. Sound familiar?
Let's personalize your content